Reproductive Endocrinology Ovarian Hormones

Comparison of the acetophenone derivative 16alpha,17alpha-dihydroxyprogesterone with other progestational steroids for masculinization of the ratfetus

Lerner LJ, Dephillipo M, Yiacas E, Brennan D, Borman A

Published September 1962 Endocrinology, 71(3), 448-451
DOI 10.1210/endo-71-3-448 PMID 14464248

RRM Academy Synopsis

Progesterone did not masculinize rat fetuses; some synthetics did

Several synthetic progestogens masculinized female rat fetuses, but progesterone did not. In this 1962 lab study, pregnant rats each received one of seven progestational steroids. The acetophenone derivative the authors set out to test left the sex ratio and sex organs unchanged, as progesterone did.

Key Findings

  • Among 809 pups delivered by untreated mothers, ano-genital distance classified 53% as female, 46% as male and 1% as indeterminate sex type.
  • The acetophenone derivative of 16α,17α-dihydroxyprogesterone left the male:female ratio unchanged and caused no virilization of the pups' internal or external sex structures. Progesterone and 17α-hydroxyprogesterone caproate gave similar results.
  • 6α-methyl-17α-hydroxyprogesterone acetate decreased the number of pups classified as female and increased those classified as intersex; some female offspring had clitoral enlargement and blind vaginae.
  • Masculinization was most pronounced with 17α-ethinyl-19-nortestosterone or its acetate. The enanthate derivative did not alter the sex ratio, although clitoral enlargement was induced in many animals.
  • Litter size stayed the same across the progestogens and doses used.

Interpretation

This controlled animal experiment used Sprague-Dawley rats. Mothers were injected daily late in pregnancy, and pup sex was classified at birth by ano-genital distance, then checked by autopsy at 21 days. The authors state that a steroid with androgenic activity in castrated male rats may virilize the rat fetus. Progesterone was the exception: it showed that activity yet did not virilize fetuses. The authors conclude that both responses should guide the choice of progestational steroids for clinical use. They also note that Revesz and colleagues saw variable clitoral enlargement with larger progesterone doses.

RRM Context

Restorative reproductive medicine starts from how the body works, so what a hormone does matters more than its label. In this 1962 study, progesterone left rat sex development normal. Several synthetic progestogens masculinized female pups. Compounds in this drug class differed in their effects on the developing rat fetus.

Abstract

A new progestational steroid, the acetophenone derivative of 16α,17α;- dihydroxyprogesterone, was compared with several progestogens for masculinizing effects on the offspring of rats treated during pregnancy. The results were similar to those obtained with progesterone and 17α-hydroxyprogesterone caproate: this new steroid did not alter the normal male:female sex ratio and did not virilize the internal or external sex structures of the newborn. The present results confirm those of others in finding that 6α-methyl-17α-hydroxyprogesterone acetate, 17α-ethinyl-19-nortestosterone and 17aethinyl- 19-nortestosterone acetate increased the number of male and intersex offspring, as determined by ano-genital measurements and masculinization of internal and external sex organs.

Topics

Related research

Reproductive Endocrinology › Ovarian Hormones › Progesterone
PMID 14464248 14464248 DOI 10.1210/endo-71-3-448 10.1210/endo-71-3-448 Lerner et al. 1962, Lerner 1962